DIA
Drug Information Association Logo

Advanced Search

MM-DD-YYYY

Add Filter

    Advanced Search

    Find Meetings & Training 

    Name Start Date Credits Format Region Location
    Basics of the IND Phase May 4, 2015 IACET Online Instruction Global Online
    Oversight of Clinical Monitoring: Trends and Strategies May 5, 2015 IACET Online Instruction Global Online
    Expert Reactor Panel: IOM Report on Sharing Clinical Trial Data May 6, 2015 Online Instruction Global Online
    Novel Data Sources: The Positive Impact of Social Media and Online Networks for Engaging with Patients May 6, 2015 Online Instruction Global Online
    Generic Drug Labeling Proposed Rule and Safety Updates May 6, 2015 Online Instruction Global Online
    FDA’s Evolving Position on the Brief Summary and Adequate Directions for Use Guidance May 6, 2015 Online Instruction Global Online
    Target Product Profile – Strategies to Optimize Drug Development, Product Labeling, and Commercialization May 6, 2015 Online Instruction Global Online
    GVP Module IX Compliant Signal Management Systems in Pharmacovigilance: A Tale of Two Experiences May 6, 2015 Online Instruction Global Online
    Complimentary Webinar - Using Revolutionary Machine Learning to Find the Most Relevant Content to Drive Informed Decisions in Regulatory Intelligence May 6, 2015 Online Instruction Global Online
    The Role of the Clinical Data Manager May 6, 2015 Online Instruction Global Online
    Implementation of the FDASIA Patient Provisions May 6, 2015 Online Instruction Global Online
    Complimentary: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs May 6, 2015 Online Instruction Global Online
    FDA’s Role in Advancing the Science of Pharmacovigilance: Tools, Methods, and Pilot Programs Under Evaluation for the Analysis of Safety Signals May 6, 2015 Online Instruction Global Online
    Variations in the European Union: CMC/Quality Changes May 6, 2015 Online Instruction Global Online
    Proarrhythmia May 6, 2015 Online Instruction Global Online
    Facets of Drug-Induced Kidney Injury and Regulatory Perspective May 6, 2015 Online Instruction Global Online
    Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury May 6, 2015 Online Instruction Global Online
    Pharmacovigilance and Risk Management: Patient Perspective May 6, 2015 Online Instruction Global Online
    Drug Safety Regulatory Requirements May 6, 2015 ACPE, IACET Online Instruction Global Online
    Premarketing Clinical Trial Safety May 6, 2015 ACPE, IACET Online Instruction Global Online
    Postmarketing Safety Management May 6, 2015 ACPE, IACET Online Instruction Global Online
    Basics of Signal Detection and Pharmacoepidemiology May 6, 2015 ACPE, IACET Online Instruction Global Online
    Safety Audits and Inspections May 6, 2015 ACPE, IACET Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 1: Fundamentals of Clinical Pharmacology: Pharmacokinetics May 6, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 2: Fundamentals of Clinical Pharmacology: Pharmacodynamics May 6, 2015 Online Instruction Global Online
    Pharmacovigilance and Global Harmonization Updates May 6, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology For Drug Development - Part 3: Principles of Modeling and Simulation May 6, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose May 6, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 5: Assessment of QT Prolongation May 6, 2015 Online Instruction Global Online
    Negotiation and Influence May 6, 2015 Online Instruction Global Online
    Introduction to Drug Safety May 6, 2015 ACPE, IACET Online Instruction Global Online
    How to Prepare for a Safety Inspection May 6, 2015 Online Instruction Global Online
    Implementation and Status of Periodic Benefit-Risk Evaluation Reporting (PBRER) in Canada May 6, 2015 Online Instruction Global Online
    Clinical Statistics for Nonstatisticians May 6, 2015 Online Instruction Global Online
    Advanced Clinical Statistics for Nonstatisticians May 6, 2015 Online Instruction Global Online
    Development of a Clinical Study Report May 6, 2015 Online Instruction Global Online
    Art of Writing a Clinical Overview May 6, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 6: Preclinical Toxicology & Safety May 6, 2015 Online Instruction Global Online
    Complimentary - Need to Reinvent the Clinical Trial? Innovate, Collaborate & Integrate May 6, 2015 Online Instruction Global Online
    Complimentary Webinar - How to Cut Clinical Trial Timelines in Half May 6, 2015 Online Instruction Global Online
    Disruptive Innovation in Medical Information May 6, 2015 Online Instruction Global Online
    A Tour of FDA May 6, 2015 Online Instruction Global Online
    A Tour of Health Canada May 6, 2015 Online Instruction Global Online
    A Tour of Health Europe May 6, 2015 Online Instruction Global Online
    Aspects of Regulatory History May 6, 2015 Online Instruction Global Online
    Bioresearch Monitoring Program (BIMO): Introduction May 6, 2015 Online Instruction Global Online
    The Clinical Development Process: Investigational Product, Plan, and Data Management May 6, 2015 Online Instruction Global Online
    Ethical Review Boards May 6, 2015 Online Instruction Global Online
    Ethics as the Foundation to Clinical Research May 6, 2015 Online Instruction Global Online
    Awareness of FDA Inspections for Pharmaceutical Manufacturers May 6, 2015 Online Instruction Global Online
    Biotechnology: An Overview of Compliance Considerations May 6, 2015 Online Instruction Global Online
    Change Control May 6, 2015 Online Instruction Global Online
    Clinical Trial Audits and Consequences of Non-Compliance May 6, 2015 Online Instruction Global Online
    Computerized Systems Inspections in the Medical Device Industry May 6, 2015 Online Instruction Global Online
    European Union Clinical Trials Directive May 6, 2015 Online Instruction Global Online
    GMP Principals of SOPs May 6, 2015 Online Instruction Global Online
    GMP Updates - Enforcement Changes at the New FDA May 6, 2015 Online Instruction Global Online
    GMPs for API Bulk Manufacturers May 6, 2015 Online Instruction Global Online
    Good Clinical Practices (GCPs) for New Product Investigations May 6, 2015 Online Instruction Global Online
    Good Laboratory Practices (GLPs) May 6, 2015 Online Instruction Global Online
    GxPs May 6, 2015 Online Instruction Global Online
    HIPAA - The Impact on Clinical Research May 6, 2015 Online Instruction Global Online
    Introduction to GMPs May 6, 2015 Online Instruction Global Online
    Investigational Product Development May 6, 2015 Online Instruction Global Online
    ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials May 6, 2015 Online Instruction Global Online
    Key Concepts of Process Validation May 6, 2015 Online Instruction Global Online
    Laboratory Specimens for Clinical Research May 6, 2015 Online Instruction Global Online
    Medical Device Safety Reporting May 6, 2015 Online Instruction Global Online
    Orientation to GMP Compliance May 6, 2015 Online Instruction Global Online
    Overview of the Clinical Research Process May 6, 2015 Online Instruction Global Online
    Part 11: Electronic Records and Signatures - Application May 6, 2015 Online Instruction Global Online
    Part 11: Electronic Records; Electronic Signatures May 6, 2015 Online Instruction Global Online
    Principles of Good Documentation May 6, 2015 Online Instruction Global Online
    Protection of Human Subjects in Clinical Trials May 6, 2015 Online Instruction Global Online
    Selecting and Managing Clinical Contract Research Organizations (CROs) May 6, 2015 Online Instruction Global Online
    Understanding Post-Approval Changes May 6, 2015 Online Instruction Global Online
    Computerized Systems Inspections in the Pharmaceutical Industry May 6, 2015 Online Instruction Global Online
    Basics of the PhRMA Code May 6, 2015 Online Instruction Global Online
    Basics of AdvaMed Code May 6, 2015 Online Instruction Global Online
    Eucomed Guidelines on Interactions with Healthcare Professionals May 6, 2015 Online Instruction Global Online
    Introduction to Medical Device Health Care Compliance May 6, 2015 Online Instruction Global Online
    Foreign Corrupt Practices Act May 6, 2015 Online Instruction Global Online
    Global Anti-bribery May 6, 2015 Online Instruction Global Online
    Variations to Marketing Authorisation in Europe May 6, 2015 Online Instruction Global Online
    Registration of Monoclonal Antibodies May 6, 2015 Online Instruction Global Online
    How to Gain Approval to Market a Generic Medicinal Product in the USA May 6, 2015 Online Instruction Global Online
    Pharmacokinetics and Pharmacodynamics in Drug Registration May 6, 2015 Online Instruction Global Online
    Implementing Risk-Based Monitoring: Practical Approaches May 6, 2015 Online Instruction Global Online
    Complimentary - Innovative Strategies for Developing Safer Cancer Therapies May 6, 2015 Online Instruction Global Online
    Complimentary - Risk-Based Monitoring: Regulatory Expectation and Operational Application May 6, 2015 Online Instruction Global Online
    Fundamentals of Project Management for Nonproject Managers May 6, 2015 Online Instruction Global Online
    Planning and Managing Your Projects May 6, 2015 Online Instruction Global Online
    Team Building and Development May 6, 2015 Online Instruction Global Online
    Preparing a Clinical Trial Budget May 6, 2015 Online Instruction Global Online
    Postmarketing Requirements: The Legal Framework, How They Are Issued, Sponsor Obligations and Challenges to Overcome May 6, 2015 Online Instruction Global Online
    Introduction to the European Union Institutions and Regulatory Authority May 6, 2015 Online Instruction Global Online
    Introduction to US Institutions and Regulatory Authority (FDA) May 6, 2015 Online Instruction Global Online
    Introduction to Japanese Institutions and Regulatory Authorities May 6, 2015 Online Instruction Global Online
    Overview of the CTD and eCTD May 6, 2015 Online Instruction Global Online
    Introduction to the International Conference on Harmonisation (ICH) May 6, 2015 Online Instruction Global Online
    The Regulatory Development of a Drug May 6, 2015 Online Instruction Global Online
    Basics of Clinical Trials May 6, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Centralized Procedure May 6, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Mutual Recognition Procedure May 6, 2015 Online Instruction Global Online
    How to Maintain Marketing Approvals in Europe for Centrally Authorised Products May 6, 2015 Online Instruction Global Online
    How to Register a New Drug in the USA May 6, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Decentralized Procedure May 6, 2015 Online Instruction Global Online
    Access to Unapproved Drugs through Compassionate Use May 6, 2015 Online Instruction Global Online
    Regulatory Requirements for the Conduct of Clinical Trials in Europe May 6, 2015 Online Instruction Global Online
    Orphan Drugs in the USA, European Union, and Japan May 6, 2015 Online Instruction Global Online
    Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs) May 6, 2015 Online Instruction Global Online
    Meeting Opportunities with Regulatory Agencies May 6, 2015 Online Instruction Global Online
    Complementary - How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality May 6, 2015 Online Instruction Global Online
    Complimentary - Regulatory Solutions in the Cloud - 10 Questions You Can't Afford NOT to Ask May 6, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 1 - Paving the Way for Greater Access To Data May 6, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward-Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 2-Connecting the Research Community: Data Sharing–Perspectives from Academia and Patient Advocacy Groups May 6, 2015 Online Instruction Global Online
    Complimentary - From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making May 6, 2015 Online Instruction Global Online
    Adverse Event Reporting Requirements: IND and Postmarketing May 6, 2015 Online Instruction Global Online
    Complimentary - The Affiliate Challenge – How to Improve Compliance and Efficiency when Working with Regional Affiliates May 6, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 1: Overall Challenge: The Vision of Better Medicines for Children May 6, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU May 6, 2015 Online Instruction Global Online
    Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children May 6, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 2: Regulatory Framework US Overview May 6, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations May 6, 2015 Online Instruction Global Online
    Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling May 6, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 7: Operational Challenges of Pediatric Clinical Trials May 6, 2015 Online Instruction Global Online
    Supplements and Other Changes to an Approved Application May 6, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada May 6, 2015 Online Instruction Global Online
    eRegulatory and Intelligence Virtual Conference May 11, 2015 Meetings Global
    Complimentary Webinar - Next Generation Feasibility: Better Planning Through Simulation May 13, 2015 Online Instruction Global Online
    Basics of the NDA Phase May 18, 2015 IACET Online Instruction Global Online
    Postmarketing Requirements: The Legal Framework, How They Are Issued, Sponsor Obligations and Challenges to Overcome May 19, 2015 ACPE, IACET Online Instruction Global Online
    How to Prepare for a Safety Inspection Jun 1, 2015 IACET Online Instruction Global Online
    FDA’s Role in Advancing the Science of Pharmacovigilance: Tools, Methods, and Pilot Programs Under Evaluation for the Analysis of Safety Signals Jun 4, 2015 Online Instruction Global Online
    Adverse Event Reporting Requirements: IND and Post-marketing Jul 13, 2015 IACET Online Instruction Global Online
    Interactions with the FDA during IND/NDA Phases Jul 16, 2015 Online Instruction Global Online
    Overview of Drug Development in Japan Sep 2, 2015 Online Instruction Global Online
    Introduction to Signal Detection and Data Mining Oct 5, 2015 IACET Online Instruction Global Online